Due to structural flexibility, RNase sensitivity, and serum instability, RNA nanoparticles with concrete shapes for in vivo application remain challenging to construct. Here we report the construction of 14 RNA nanoparticles with solid shapes for targeting cancers specifically. These RNA nanoparticles were resistant to RNase degradation, stable in serum for >36 h, and stable in vivo after systemic injection. By applying RNA nanotechnology and exemplifying with these 14 RNA nanoparticles, we have established the technology and developed "toolkits" utilizing a variety of principles to construct RNA architectures with diverse shapes and angles. The structure elements of phi29 motor pRNA were utilized for fabrication of dimers, twins, trimers, triplets, tetramers, quadruplets, pentamers, hexamers, heptamers, and other higher-order oligomers, as well as branched diverse architectures via hand-in-hand, foot-to-foot, and arm-on-arm interactions. These novel RNA nanostructures harbor resourceful functionalities for numerous applications in nanotechnology and medicine. It was found that all incorporated functional modules, such as siRNA, ribozymes, aptamers, and other functionalities, folded correctly and functioned independently within the nanoparticles. The incorporation of all functionalities was achieved prior, but not subsequent, to the assembly of the RNA nanoparticles, thus ensuring the production of homogeneous therapeutic nanoparticles. More importantly, upon systemic injection, these RNA nanoparticles targeted cancer exclusively in vivo without accumulation in normal organs and tissues. These findings open a new territory for cancer targeting and treatment. The versatility and diversity in structure and function derived from one biological RNA molecule implies immense potential concealed within the RNA nanotechnology field.
INTRODUCTION
One of the two approaches in nanotechnology is bottom-up assembly that uses modified or engineered building blocks (Schmidt and Eberl 2001; Balzani et al. 2002; Seeman and Belcher 2002; Shu et al. 2004; Xiao et al. 2009a Xiao et al. ,b, 2010 . RNA is versatile in structure and function and even possesses enzymatic activity characteristic of some proteins (Nilsen 2007; Guo 2010; Shukla et al. 2011) . It can also be designed, predicted, synthesized, and manipulated with a level of simplicity similar to that of DNA (Jaeger and Leontis 2000; Hansma et al. 2003; Grabow et al. 2011) . Thus, RNA is a unique building block for the assembly of nanoparticles (Wilcox et al. 1992 ; Leontis et al. 2006; Guo 2010; Guo et al. 2012a,b) . Several naturally or artificially functional RNAs, such as small interfering RNAs (siRNAs) (Brummelkamp RNase degradation. Due to structural flexibility, RNase sensitivity, and serum instability, the construction of RNA nanoparticles with concrete shapes for in vivo application remains challenging. The field of RNA nanotechnology has emerged only recently, and new methods for RNA nanoparticle constructions are in high demand presently. Here we report the construction of 14 different RNA nanoparticles with solid shapes for targeting cancers specifically.
RNA is a polynucleic acid that possesses all the favorable attributes of conventional polymers. Several structural features of the bacteriophage phi29 packaging RNA (pRNA) are attractive for bottom-up assembly of RNA nanoparticles (Fig. 1A) . Each pRNA contains a helical domain (5 ′ /3 ′ paired ends denoted as the foot) ( Fig. 1B ; Cairns et al. 1988; Zhang et al. 1994; Reid et al. 1994a,b,c; Garver and Guo 1997) , a central domain (bases 23-97) containing right-and left-hand loops for intermolecular interactions ( Fig. 1B ; Reid et al. 1994a; Garver and Guo 1997; Chen et al. 1999 Chen et al. , 2000 , and a threeway junction (3WJ) motif (see Figs. 1B, 5A below). Here we report the development of an array of techniques, or "toolkits," derived from pRNA that utilize a variety of principles to construct RNA architectures with diverse shapes and angles. The resulting RNA nanoparticles are homogeneous with defined structure and stoichiometry and can be generated in a controllable and predictable manner. These toolkits will be very useful to construct higher-ordered, diverse RNA nanostructures with multiple functionalities as a polyvalent delivery system for nanotechnology and nanomedicinal applications.
The incorporation of all functionalities was achieved prior to the assembly of the RNA nanoparticles, thus ensuring the production of homogeneous therapeutic nanoparticles with appropriate quality control for medical applications. The annealing of therapeutic RNA modules to the RNA or DNA (Lee et al. 2012a ) nanoparticles after the assemblage of a scaffold has been reported. However, our novel bottom-up approach has demonstrated the feasibility of incorporation of all functionalities prior to the assemblage of RNA nanoparticles, without affecting the folding or function of both the core scaffold and the individual modules. This approach also ensures the high efficiency and homogeneity of the particles and avoids the dissociation of the RNA nanoparticles in vivo due to the presence of nicks in the component RNA functional modules of the RNA nanoparticles.
RESULTS
Toolkit I: Hand-in-hand toolkit for assemblage of pRNA nanoparticles by extending interlocking loops Previously, we have reported that the interlocking loops of phi29 pRNA can be used for constructing RNA dimers, trimers, and hexamers through hand-in-hand interactions (Guo et al. 1998 Chen et al. 1999; Shu et al. 2003 Shu et al. , 2011c Khaled et al. 2005) . However, the resulting particles were not found to be thermodynamically stable enough for nanotechnological applications. In this study, we tried to produce stable interlocking loops for nanoparticle construction by extending the loop sequences. But, random extension of the loop sequences failed due to interferences in RNA folding and 3D conformation. Extensive investigations have also resulted in a toolkit with a set of hand-in-hand loop sequences that can be used for the construction of stable RNA polygonal nanoparticles (Fig. 1C) . The loop-extended pRNAs were constructed by replacing the complementary regions in the wildtype pRNA 4-nt R-and L-loops with a series of loop sequences (Fig. 1C) . Since altering the nucleic acid sequences may have affected the global folding of pRNA molecules, the pRNA with re-engineered loop sequences were thoroughly analyzed with the online RNA folding program Mfold (Zuker 2003) . A total of nine pairs of hand-in-hand loop sequences with predicted appropriate folding were selected out from the library and then used for constructing a variety of RNA polygonal particles via hand-in-hand interactions (Supplemental Fig. 1A ).
The formation of pRNA homo-dimers is an excellent system by which to assay loop-loop interactions since the paired loop sequences are assigned to R-and L-loops within the same pRNA. The appropriately folded pRNA monomers will form self-dimers via the complementary R-and L-loops in the presence of Mg 2+ . After transcription, nine homo-dimers were refolded in TMS buffer for 1 h at 37°C and analyzed with 6% native PAGE to assay for dimer formation. The dimers were found to have migrated slower than the monomers, as shown in the native PAGE. Seven pairs of loop-loop sequences were able to facilitate homo-dimer formation (Supplemental Fig.  1B) , and two pairs of loop-loop sequences showed weak dimer formation, indicating that the pRNA structure misfolded after the alteration of the loop sequences. The seven pairs of loop-loop sequences that exhibited dimer formation were further investigated as potential candidates for building pRNA nanoscale assemblies. Using reengineered loop-loop interactions, pRNA dimer (ExAb
were assembled in the presence of Mg Toolkit II: Foot-to-foot toolkit for assemblage of higher-ordered pRNA nanoparticles based on palindrome sequences A palindrome sequence is one that reads the same in the 5 ′ -to-3 ′ direction on one strand or from the 5 ′ -to-3 ′ direction on the complementary strand. Six-nucleotide palindrome sequences were designed following the chart in Figure 3 and introduced at the 3 ′ -end of the RNA building block. These RNA building blocks were able to form foot-to-foot self-dimers via intermolecular interactions mediated by the palindrome sequences. In a similar fashion, palindrome sequences were utilized to bridge RNA nanostructures, motifs, and scaffolds for the self-assembly of RNA hexamers, octamers, decamers, dodecamers, or any other duplex with an even number of subunits and were assembled into foot-to-foot structures, as revealed by native PAGE (Fig. 4) and AFM imaging (see Fig. 6F -J, below).
Toolkit III: Design of branched pRNA nanoparticles based on the 3WJ motif Large macromolecular assemblies of RNA nanoparticles were constructed via intramolecular interactions utilizing junction motifs. The pRNA-3WJ core was assembled with an unusually high efficiency from three RNA oligos mixed in the proper stoichiometric molar ratio in the absence of any metal ions (Shu et al. 2011a) , as shown by native PAGE (Fig. 5A,C) . The lengths of the helices H3-1, H3-2, and H3-3 were 8 bp, 9 bp, and 8 bp, respectively, and the resulting nanoparticles constructed were stable even under strong denaturing conditions.
The pRNA-X motif was constructed by opening the R-loop of the pRNA subunit and inserting a 9-bp sequence, thereby forming a double helical segment (H4-2) and extending the H4-3 helix by 4 bp ( Fig. 5B ; Haque et al. 2012) . The length of the helices H4-1, H4-3, and H4-4 were each 8 bp long, while H4-2 was 9 bp long. The X-shaped motif could then be assembled from four RNA fragments mixed in a 1:1:1:1 ratio with a high affinity in absence of metal salts (Fig. 5C ). Self-complementary palindrome sequences could then be added to either the 5 ′ -or 3 ′ -end of one of the strands of the core motifs to bridge two X-motifs harboring a total of six functionalities via intermolecular interactions, thereby generating a footto-foot branched hexamer (Fig. 5C ).
Arm-on-arm branched hexavalent RNA nanoparticles were constructed from two 3WJ cores. A major consideration was to minimize the misfolding of the resulting complex after fusion of the sequences. One of the approaches involved the utilization of the thermodynamic properties of the strong-folding RNA cores, exemplified by the forward sequences and reverse sequences of the pRNA-3WJ core that generated two self-folded, stable scaffolds. Each of the three arms of the 3WJ harbored an overhanging, reverse 3WJ fragment that served as a sticky end to carry one of the monomer constructs, and produced either a trimeric (three identical molecules or structures) complex or a triplet (three varied molecules or structures) (Fig. 5C ). Similarly, hexameric complexes were assembled efficiently in one step from RNA fragments with the following stoichiometric ratio: (a 3WJ-FWD + a 3WJ-REV ):(a 3WJ-FWD + a 3WJ-REV ):(a 3WJ-FWD + a 3WJ-REV ):b 3WJ :c 3WJ = 1:1:1:3:3.
Each of the four aforementioned constructs could harbor functional modules at each of the branches, without affecting the folding of the core scaffolds. To test this, monomeric pRNA subunits were placed at each of the branches, and AFM images were produced that strongly indicated the formation of homogenous RNA nanoparticles with the desired structure and stoichiometry ( Fig. 6K-N) .
Functional assays for each module incorporated into pRNA nanoparticles
Similar to the principles of the fields of DNA and protein biotechnology and nanotechnology, one crucial factor to consider in the construction of RNA nanoparticles is the misfolding of the resulting complex during assembly. Using Toolkits I, II, and III, the resultant misfolding was significantly minimized. We constructed multivalent RNA nanoparticles harboring functional modules, such as siRNA, ribozymes, aptamers, and the folate (FA) ligand. It was revealed that (1) the incorporation of functional modules did not affect the folding of the central scaffolds and (2) the RNA modules within the nanoparticles folded into their respective authentic structures and retained their biological functions independently. Our assay revealed that the folding of functionalities was predictable and that each incorporated module folded and functioned independently within the nanoparticles.
Assessment of malachite green fluorescence
The fused malachite green (MG)-binding aptamer, in both the monomeric form and pRNA tetramer assemblies, retained its capacity to bind MG dye, as revealed by fluorescence emissions in native PAGE and by fluorometry ( Fig. 7A ; Baugh et al. 2000; Shu et al. 2011a; Reif et al. 2013 ). Free MG is not fluorescent by itself but emits fluorescent light only after binding to the RNA aptamer, a fact that supports our finding.
Assay for streptavidin binding
Upon incubation with streptavidin (STV) resin, pRNA tetramers harboring the STV-binding aptamer (Srisawat and FIGURE 4 . Native PAGE gel demonstrating the efficient self-assembly of RNA nanoparticles using Toolkit II based on foot-to-foot palindrome sequence. Engelke 2001) bound the STV resin and then were eluted out by biotin (Fig. 7B) . Tetramers without the STV-binding aptamer did not appear in the elution fractions (Fig. 7B) . The results demonstrated that the STV aptamer in the tetrameric complex maintained structural integrity and function after fusing with pRNA, as revealed by native PAGE. The tetramers that also contained the MG binding aptamer exhibited binding and staining, indicating that other functions were retained within tetramers after purification, as shown in Figure 7B . This STV-binding aptamer could potentially be utilized as the method of RNA nanoparticle purification.
Retention of catalytic activity of the hepatitis B virus ribozyme
Hepatitis B virus (HBV) ribozymes were able to cleave the 135-nt HBV RNA genome substrate into two fragments (60 nt and 75 nt) after being incorporated into the tetrameric pRNA nanoparticle (Fig. 7C) , indicating that the ribozyme retained correct folding and function after it was incorporated into the pRNA nanoparticles.
Targeted gene silencing of luciferase
A dual-luciferase reporter assay system was used to measure the gene silencing effects of pRNA tetrameric constructs harboring four different siRNAs targeted toward the firefly luciferase gene (Shu et al. 2011b ). The relative luciferase activity is proportional to the expression level of the firefly luciferase gene when normalized with the activity of the internal control, Renilla luciferase, which remains unaffected against siRNA. The results indicated that pRNA tetramers harboring four different firefly luciferase siRNAs displayed ∼70% decrease in firefly luciferase gene expression, compared with scrambled control siRNA (Fig. 7D) .
Internalization of branched pRNA nanoparticles harboring FA Many kinds of cancer cell lines, especially those from epithelial origins, overexpress FA receptors (FRs) on a plasma membrane by >1000-fold. FA has been extensively used as a targeting ligand, because it can be efficiently internalized into cancer cells via FR-mediated endocytosis (Lee and Low 1994; Lu and Low 2002) . Accordingly, FA was incorporated in pRNA branched 3WJ nanoparticles to facilitate cancer cell targeting (Lu and Low 2002; Guo et al. 2006; Shu et al. 2011a) . A Cy3 dye moiety was also incorporated into pRNA 3WJ strands by chemical conjugation, to serve as a fluorescent marker (Shu et al. 2011a ). The pRNA nanoparticles harboring FA and Cy3 labels were compared with negative control nanoparticles harboring NH 2 and Cy3 labels. Confocal imaging indicated binding of the pRNA nanoparticles harboring FA and their entry into the targeted cells, as demonstrated by the colocalization and overlap of the fluorescent 3WJ-pRNA nanoparticles (red) and cytoplasm (green) (Fig. 8A) .
In vivo targeting to xenograft tumors pRNA-X nanoparticles were constructed carrying FA to serve as a ligand for binding to cancer cells and Alexa Fluor 647 as a marker for imaging. The nanoparticles were systemically injected (via the tail vein) into athymic nude mice bearing KB cell xenografts in their subcutaneous flanks. Whole-body imaging revealed that fluorescence was located specifically in the tumor xenografts, expressing the FR 24 h after injection (Fig.  8B, left column) . Interestingly, the fluorescent nanoparticles were not detected in any other organs in the body 3 h after injection, indicating that the particles were cleared from the normal organs quickly and were not trapped in the liver, lungs, or kidneys after systemic injection (Fig. 8B, right column) . These results were very different from other studies that have shown nanoparticles that have accumulated in the liver, lungs, spleen, and kidneys and required 12-96 h to clear from the organs, as revealed by imaging (Altinoglu et al. 2008; Barth et al. 2010; Abdelmawla et al. 2011; Lee et al. 2012c; Ma et al. 2012 ). The ability of pRNA nanoparticles to effectively and selectively target cancer cells by this process would make this delivery system attractive for future clinical developments.
One concern of applying RNA nanoparticles for in vivo delivery, though, is the sensitivity of RNA to RNase degradation. To solve this, 2 ′ -fluorine-deoxy-CTP (2 ′ -F-dCTP) and 2 ′ -fluorine-deoxy-UTP (2 ′ -F-dUTP) were incorporated into the RNA strands (Liu et al. 2010 ). The 2 ′ -F-dCTP & dUTP (2 ′ -F C&U) modified RNA were found to be able to survive in 10% serum treatment for up to 36 h (Supplemental Fig.  3A ), compared with unmodified RNA, which could only last for 2 h. The modified RNA could also survive in various concentrations of RNase A, compared with unmodified RNA, which only survived in very diluted RNase (Supplemental 3B ). In order to determine whether 2 ′ -F C&U modified RNA display a higher thermodynamic stability than unmodified RNA, the stability of unmodified and 2 ′ -F C&U modified RNA assemblies isolated from native PAGE was compared by temperature gradient gel electrophoresis (TGGE) at 700 nM. Two constructs, a dimer and a hexamer, were assayed by TGGE, imaged, and then analyzed by ImageJ. The melting temperature (T m ) of each RNA nanoparticle was obtained by fitting the melting curves using nonlinear Sigmoidal fitting (T m of unmodified dimer = 43.8°C; T m of 2 ′ -F C&U modified dimer = 52.8°C; T m of unmodified hexamer = 42.2°C; T m of 2 ′ -F C&U modified hexamer = 50.9°C). For all the constructs tested (dimer and hexamer), the 2 ′ -F C&U modified RNA assemblies (dimer or hexamer) were determined to be stable in temperatures ∼8°C-10°C higher than the conditions of the unmodified counterparts (Fig. 9 ). These results demonstrate the chemically and thermodynamically stable features of modified RNA nanoparticles for diverse applications in nanotechnology and nanomedicine.
DISCUSSION
Several mechanisms of RNA intermolecular interaction have been reported to play roles for the assembly of diverse RNA nanoparticles. These include (1) hand-in-hand (looploop interactions), as demonstrated in bacteriophage phi29 pRNA dimer, trimer, and hexamer formations (Guo et al. 1987 (Guo et al. , 1998 Shu et al. 2004 Shu et al. , 2007 ; RNA nanorings based on RNAI/II inverse kissing complexes (Yingling and Shapiro 2007; Afonin et al. 2011; Grabow et al. 2011) ; kissing loops of HIV RNA (Chang and Tinoco 1994; Bindewald et al. 2008 ) and the hand-in-arm interactions of Drosophila bicoid mRNA (Wagner et al. 2004) ; (2) palindrome sequence-mediated formation of pRNA dimers, tetramers, and arrays (Shu et al. 2004) ; (3) RNA motifs as LEGO pieces to build quaternary structures via nontemplated assemblies including tecto-RNA, two-way junctions (2WJs), 3WJs, and four-way junctions (4WJs), and self-assembly by colE1 kissing loop interactions (Prats et al. 1990; Clever et al. 1996; Mujeeb et al. 1998; Jaeger and Leontis 2000; Lilley 2000; Shu et al. 2011a; Haque et al. 2012) ; (4) extension of arms of thermodynamically stable core to carry multiple therapeutic small RNAs (Shu et al. 2011a; Haque et al. 2012 ); (5) use of RNA binding proteins to serve as scaffolds for the formation of nanostructures, such as equilateral triangle constructs, where three proteins are bound to an RNA scaffold containing a kink-turn motif for protein binding (Schroeder et al. 2010; Ohno et al. 2011 ); and (6) combination of rolling circle transcription of RNA and self-assembly to produce giant spherical RNA particles (Lee et al. 2012b) . Recently, we have reported the fabrication of ultrastable RNA nanoparticles using the phi29 3WJ core to carry siRNA, ribozymes, and aptamers for cancer targeting (Shu et al. 2011a; Haque et al. 2012) , using the aforementioned approach 4. The thermodynamically stable pRNA-X nanoparticles are assembled from four small pieces of RNA fragment, which has proven to be stable in serum, remain intact at ultralow concentrations, and be resistant to denaturation in 8 M urea. The slope of the T m curve is close to 90° (Shu et al. 2011a; Haque et al. 2012 ) suggesting thermostability. More importantly, various functionalities such as siRNA, ribozyme, or receptor-binding aptamer incorporated into the 3WJ core resulted in the formation of polyvalent particles displaying all the authentic functionalities in vitro and in vivo. Systemic injection of these RNA nanoparticles to mice showed that the RNA nanoparticles target specifically to the xenograft without accumulating in normal organs and tissues (Shu et al. 2011a; Haque et al. 2012) . In this report, we extended our previous work in the aforementioned approach 1, in combination with approaches 2-5 to construct versatile RNA nanoparticles. Three "toolkits" were generated as hand-inhand interaction (Toolkit I), palindrome sequences for foot- to-foot interaction (Toolkit II), and junction motifs from the phi29 motor pRNA to build larger macromolecular assemblies via intermolecular self-assembly (Toolkit III). Fourteen different homogenous RNA nanoparticles were fabricated in a controlled manner with defined size, structure, and stoichiometry. All the constructed RNA nanoparticles are thermodynamically and chemically stable and can harbor multiple functional modules (up to a maximum 12). We demonstrated incorporation of these functional modules by in vitro and in vivo functional assays. The results suggest that the toolkits can be broadly applied to construct versatile RNA nanoparticles for diverse applications in nanotechnology and nanomedicine.
MATERIALS AND METHODS

Nomenclature
Following standard pRNA nomenclature (Shu et al. 2011b) , the right-hand (R-loop) sequence was assigned an uppercase letter (i.e., A, B, …); the left-hand (L-loop) sequence, a lowercase letter with a prime (i.e., a ′ , b ′ , …). A pair of the same uppercase and lowercase letters (e.g., Aa ′ ) designated a complementary sequence in the R/L interlocking loop, while different letters indicate a lack of complementarity in the interlocking sequence. To distinguish from the wild-type pRNA, "Ex" was added before the letters (e.g., ExAa ′ ) to indicate that the interlocking loop-loop interaction was extended.
The 3WJ domain of phi29 pRNA was constructed using three RNA oligos, denoted as a 3WJ , b 3WJ , and c 3WJ. The three branches were named H3-1, H3-2, and H3-3, respectively (Fig. 5A) . The 3WJ-derived, X-shaped pRNA was constructed using four RNA oligos and was denoted as a X , b X , c X , and c 3WJ . The four branches were named H4-1, H4-2, H4-3, and H4-4, respectively (Fig. 5B) .
In vitro synthesis, purification, and assay of RNA strands for nanoparticle assembly Long RNA strands, with and without 2 ′ -F-C&U modification, were synthesized by enzymatic methods, according to the method previously described (Zhang et al. 1994; Liu et al. 2010 ). Short DNA and RNA oligos, with and without 2 ′ -F-C&U modification, were synthesized chemically by Integrated DNA Technologies and TriLink (Supplemental Tables 1-3) .
Higher-order hand-in-hand pRNA polyvalent nanoparticles were formed by mixing the required subunits at an equal molar ratio in TMS buffer (5 mM MgCl 2 , 100 mM NaCl, 89 mM Tris-HCl at pH 7.6) for 1 h at 37°C and assayed with native 6% PAGE gel run in TBM buffer (5 mM MgCl 2 , 200 mM boric acid, 89 mM TrisHCl at pH 7.6) for 3-4 h at 4°C. Foot-to-foot RNA complexes were constructed by extending the 3 ′ -end of ExAb ′ with a palindrome sequence (5 ′ -CGAUCG-3 ′ ) and assayed by 4% native PAGE gel run in TBM buffer. 
AFM imaging
RNA nano-assemblies were imaged using specially modified mica surfaces (APS mica) (Lyubchenko and Shlyakhtenko 2009 ) with a MultiMode AFM NanoScope IV system (Veeco), operating in tapping mode, according to the method previously reported (Shu et al. 2011a ).
Assay for each functional module incorporated within pRNA nanoparticles
Fluorescence assay for MG binding aptamer A pRNA tetramer harboring an MG binding aptamer and a monomer also harboring an MG binding aptamer (100 nM) were mixed with MG dye (2 µM); the fluorescence was measured using a fluorospectrometer (Shu et al. 2011a ). An pRNA tetramer without the MG binding aptamer served as a negative control, while an MG binding aptamer by itself served as the positive control. The same samples were also analyzed by 6% native PAGE run in TBM running buffer for 3-4 h at 4°C. The gel was stained with 5-10 µM MG in binding buffer and imaged by Typhoon FLA 7000 (GE Healthcare).
Binding assay for the STV-binding aptamer pRNA tetramers harboring STV-binding aptamers were premixed and preassembled in binding buffer (PBS with 10 mM Mg 2+ ) before incubation with STV Agarose resin (Thermo Scientific). Fifty microliters of STV resin was equilibrated at room temperature and washed with binding buffer. The tetramers harboring STV-binding aptamers (total, ∼4.8 μg) were added to each tube and incubated with the resin for 1 h at room temperature. Tetramers without an STV-binding aptamer served as a negative control. After incubation, the resin was spun at 500g for 1 min, and the supernatant (pass through) was removed. Then, 50 μL of binding buffer was added to the mixture and incubated for 15 min to wash the resin seven times (washes 1-7). RNA was eluted by 5 mM biotin. The samples were analyzed with 6% native PAGE run in TBM buffer and visualized by MG staining.
Activity assay for HBV ribozyme HBV ribozyme activity was determined, according to the method reported previously Shu et al. 2011a) . Briefly, HBV RNA substrate was fluorescently labeled with Cy3 (Mirus) and incubated with a pRNA tetramer harboring a HBV ribozyme (1:2 and 1:4 molar ratio). The pRNA/HBV ribozyme served as a positive control , and a pRNA tetramer harboring a disabled HBV ribozyme was used as a negative control.
In vitro binding and entry of pRNA nanoparticles into targeted cells KB cells (ATCC) were grown on glass coverslides in FA-free medium overnight. Cy3-labeled pRNA nanoparticles harboring a FA ligand were incubated with the cells for 2 h at 37°C, and imaged by confocal microscopy, according to the method previously reported (Shu et al. 2011a, b) . A FA-free pRNA nanoparticle served as a negative control.
Assay for the silencing of luciferase genes in cancer cell model Gene silencing assays were performed by cotransfecting 1.25 nM pRNA tetramer harboring firefly luciferase siRNA (Nakashima et al. 2011 ) with both pGL-3 and pRL-TK (Promega) plasmids coding for firefly and Renilla luciferase, respectively. The latter served as an internal control to normalize the luciferase data (Dual-Luciferase Reporter Assay System; Promega). pRNA tetramers harboring scrambled sequences served as a negative control.
Animal trial: in vivo targeting of tumor xenografts by systemic injection of pRNA nanoparticles NOD/SCID IL2Rγ-null male mice (7 wk old) were maintained on a FA-free diet for 2 wk. The mice were then injected with 5 × 10 6 KB cells and maintained for 3 wk to allow tumor engraftment. Tumor xenograft was apparent ∼2 wk after injection of KB cells. The mice were then injected through the tail-vein with 250 µM (76 µL) pRNA-X nanoparticles harboring FA and Alexa Fluor 647 (Invitrogen) as a label. The mice were killed 24 h after injection and whole-body imaging was conducted using a MultiSpectral FX (Kodak Carestream) with a multi-angle 2D performance station. Following whole-body imaging, the mice were dissected and the major organs were isolated for imaging.
Temperature gradient gel electrophoresis
For TGGE analysis, the experimental setup was adjusted to have a linear temperature gradient perpendicular to the electric field. The temperature gradient was set from 26.1°C to 68.8°C. A 10 μL RNA sample (∼700 nM) was combined with 2 μL of gel loading buffer and run on 6% native PAGE at 20 W for 1 h. 10 mM MgCl 2 was present in both gel and electrophoresis buffer. The gels were stained with ethidium bromide and imaged by Typhoon FLA 7000 (GE Healthcare). The dimer or hexamer fraction within the total RNA was analyzed by ImageJ, and the melting curve of each construct was fitted using nonlinear Sigmoidal fitting.
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